Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AMMELGOEI AS
AS
Active
Org 931583840
Blidensolstredet 5, 4005 Stavanger
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 341K
+46% vs 2024
EBITDA margin
-253.3%
-50% vs 2024
Equity ratio
99.0%
Financial strength
Net profit 2025
NOK 1,7M
-88% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2023
-1M
-100%
2024
-1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 341K
+46%
EBITDA
NOK -863K
-50%
Net profit
NOK 1,7M
-88%
Total assets
NOK 18,8M
+10%
Equity
NOK 18,6M
+10%
Employees
2
—
Company information
Legal name
AMMELGOEI AS
Org number
931583840
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15. juni 2023
Share capital
NOK 60 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Investering i andre selskaper, samt annen investeringsvirksomhet.
Contact
Address
Blidensolstredet 5, 4005 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
-1M
2024
-1M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
0
233
341
Staff expenses
−19
−635
−1 086
EBITDA
−37
−577
−863
Depreciation & amort.
−0
−0
−0
EBIT
−37
−577
−863
Net financials
0
14 474
2 455
Profit before tax
−37
13 897
1 592
Tax
−9
−79
−84
Net profit
−27
13 976
1 676
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
3 093
17 051
18 765
Equity
2 934
16 910
18 586
Long-term debt
14
0
0
Short-term debt
144
140
179
Total debt
158
140
179
Financial ratios
5-year trend
EBITDA margin
-253.3%
This company
15.8%
Market median
-1703% vs market
2023
2025
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
2023
2025
Return on equity
9.0%
This company
18.4%
Market median
-51% vs market
2023
2025
Net profit margin
491.9%
This company
8.1%
Market median
+5973% vs market
2023
2025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
2023
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EF
Erik Franciscus Godefridus De Beer
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KB
Kjersti Buanes
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AMMELGOEI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Erik Franciscus Godefridus De Beer
Chief Executive Officer
0 companies
Kjersti Buanes
Board of Directors
0 companies